Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 135

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 135
---
27.7 25.2 77.4 75.0 Restructuring and other (income) charges, net (2)1.0 3.3 10.1 8.3 Goodwill impairment charge (3)— — 183.8 306.6 Acquisition and other-related (income) costs, net (4)— (0.1)— — (Gain) loss on strategic investments (5)— 2.2 2.5 2.1 Proxy contest charges (6)— — 8.2 — Portfolio review expenses (7)1.1 — 1.1 — Adjusted EBITDA from continuing operations (Non-GAAP)$110.4 $108.4 $302.8 $296.7 Net income (loss) from discontinued operations (GAAP)$2.7 $(154.7)$(11.0)$(305.9)Provision (benefit) for income taxes on discontinued operations(1.0)(37.2)(4.3)(73.9)Interest expense, net— — — — Depreciation and amortization0.3 1.0 1.1 8.1 Restructuring and other (income) charges, net (8)8.8 83.6 33.9 154.5 Goodwill impairment charge (8)— — — 42.5 Acquisition and other-related (income) costs (8)— — — — Loss on CTO resales (8)— 0.8 — 50.8 CTO supply contract termination charges (8)— 100.0 — 100.0 (Gain) loss on strategic investments (8)— 4.5 — 9.3 Adjusted EBITDA from discontinued operations (Non-GAAP)$10.8 $(2.0)$19.7 $(14.6)Total Adjusted EBITDA (Non-GAAP)$121.2 $106.4 $322.5 $282.1 

_______________

(1) Refer to Note 14 for more information.

(2) We regularly perform strategic reviews and assess the return on our operations, which sometimes results in a plan to restructure the business. These costs are excluded from our reportable segment results and for the purposes of